Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism

Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism

Abstract Background Data that guide selection of differing anticoagulant regimens for specific cancer-associated venous thromboembolism (VTE) are lacking. We aimed to compare the efficacy and safety of rivaroxaban and low-molecular-weight heparin (LMWH) against nonhigh-risk pulmonary embolism (PE) i...

Full description

Bibliographic Details
Main Authors: Yijun Song, Dawei Yang, Dongni Hou, Jun She, Yuanlin Song
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Thrombosis Journal
Subjects:
Lung cancer
Pulmonary embolism
Rivaroxaban
Low-molecular-weight heparin
Initial anticoagulation
Online Access:https://doi.org/10.1186/s12959-023-00453-y

Internet

https://doi.org/10.1186/s12959-023-00453-y

Similar Items